Antifibrotic effect of novel neutrophil gelatinase-associated lipocalin inhibitors in cardiac and renal disease models

Neutrophil gelatinase-associated lipocalin (NGAL) is involved in cardiovascular and renal diseases. Gene inactivation of NGAL blunts the pathophysiological consequences of cardiovascular and renal damage. We aimed to design chemical NGAL inhibitors and investigate its effects in experimental models...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Sci Rep
Autors principals: Bonnard, Benjamin, Martínez-Martínez, Ernesto, Fernández-Celis, Amaya, Pieronne-Deperrois, Marie, Do, Quoc-Tuan, Ramos, Isbaal, Rossignol, Patrick, Zannad, Faiez, Mulder, Paul, Ouvrard-Pascaud, Antoine, López-Andrés, Natalia, Jaisser, Frédéric
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2021
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7844219/
https://ncbi.nlm.nih.gov/pubmed/33510370
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-021-82279-0
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars